| Literature DB >> 10431609 |
R F Schinazi1, E Ilan, P L Black, X Yao, S Dagan.
Abstract
Reliable cell-based assays and animal models have been developed for evaluating agents against hepatitis B virus. Although much progress has been made, in vitro and in vivo assays for hepatitis C virus are still on the horizon. Advances towards establishing inexpensive and reliable experimental models have accelerated the development of therapeutic modalities for these life-threatening viral infections. The characterization of well-defined viral targets coupled with improved molecular diagnostic technologies have illuminated this field.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10431609 DOI: 10.1177/095632029901000301
Source DB: PubMed Journal: Antivir Chem Chemother ISSN: 0956-3202